Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Improved connectivity with Vehco Connect, the new green onboard computer

Vehco introduces the 5[th] generation of Vehco Connect, an onboard computer that is installed in commercial vehicles to gather data from the field to make it available for the drivers and the transport management team. The new computer is based on a cutting-edge design with possibilities to connect with most possible devices over Bluetooth or USB. For the users it means greater flexibility and higher productivity. Vehco Connect gathers vehicle information and makes it available for the Transport Managers in Vehco Weboffice (a webbased office application) and for the drivers in their

Read original

Cantargia receives Notice of Allowance in the US for the CAN04 patent application

The United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Cantargia AB’s (“Cantargia”) patent application for its CAN04 product candidate, which means that the USPTO intends to approve the company’s application. Cantargia has previously received an intention to grant notification for CAN04 in Europe.The patent application, no. 15/255,585, for which the USPTO has granted Notice of Allowance refers to the company’s CAN04 product candidate. The patent protects Cantargia’s product candidate, the CAN04 antibody, which is targeted against the IL1RAP target

Harvard Medical School spotlight HoloMonitor-based research

Harvard Medical School recently spotlighted that scientists with HoloMonitor have been able to discriminate aggressive blood vessel forming tumor cells from more harmless tumor cells, lacking this ability. Read the article here . “Our hope is that one day, this technology [HoloMonitor] can provide useful clinical information that could be used to guide personalized therapies based on someone’s precise tumor phenotype [characteristics],” said Jing Huang, scientist at Boston Children’s Hospital. For more information about the research at

Enterspace to open Sweden's largest VR centre in Stockholm

Swedish virtual reality (VR) company Enterspace, a company within the Starbreeze  Group, has confirmed it will open a new VR centre in Stockholm in the fall of 2017. The 900-square meter debut Enterspace VR centre will include both VR experiences and a dedicated café bar.Enterspace promises high quality VR experiences and an inspiring meeting place for visitors to socialize before or after an experience - a place for those with curious minds to sample an entirely new form of entertainment, presented with VR technologies unavailable at home. Enterspace

Swedish healthcare provider selects Sectra’s digital pathology solution for primary diagnostics

Linköping, Sweden – June 21, 2017 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) announces that Västernorrland County Council, in Sweden, orders Sectra’s solution for storing and reviewing digital pathology images. A digital pathology solution contributes to improving cancer care by providing shorter lead times. The solution will be used for primary diagnostics and will enable a deeper collaboration between both physicians and medical disciplines.Digital management of pathology examinations enables fast image access and facilitates

Farstad Shipping ASA – Key date announcement

Skudeneshavn, Ålesund and Limassol, 21 June 2017 Reference is made to previous stock exchange notices regarding the proposed mergers between (i) Farstad Shipping ASA ("FAR") and Solship Invest 2 AS with the latter as the surviving entity and with settlement in Solstad Offshore ASA ("SOFF") shares, (ii) Deep Sea Supply Plc ("DESSC") and Solship Sub AS with the latter as the surviving entity (the "DESSC Merger I") and (iii) Solship Sub AS and Solship Invest 3 AS with the latter as the surviving entity and with settlement in SOFF shares (the "DESSC Merger II"), together referred as the "

SEK adopts the Equator Principles

The Swedish Export Credit Corporation (SEK) announces its adoption of the Equator Principles, a globally recognized benchmark for determining, assessing and managing environmental and social risk in bank financed projects. To date, 90 international financial institutions in 37 countries have signed up to the Equator Principles. As an export credit institution, SEK already applies sustainability risk assessments in accordance with the OECD frameworks and other relevant international frameworks for projects and export credits. - The Equator Principles will add a tool in our environmental

Balder acquires four properties near the central station in central Copenhagen

Fastighets AB Balder has agreed to acquire four hotel properties in central Copenhagen for approximately 1,000 million SEK. The four properties are all located next to the central station in Copenhagen and are today run under the names Star, Mercur, Richmond and Plaza. Balder will sign long term lease agreements with Ligula Hospitality Group to operate all four hotels. The transaction will close during the third quarter.   For further information, please contactCEO Erik Selin, tel. +46 706 074 790 orHead of Finance Marcus Hansson, tel. +46 768 369 848    Fastighets AB

Immunovia’s IMMray™ presents biomarkers that differentiates Rheumatoid Arthritis from other autoimmune diseases with 89% accuracy

LUND, Sweden - Immunovia today announced that they have completed the analysis of the three other autoimmune diseases included in the previously reported large, retrospective autoimmune disease study, performed in collaboration with Department of Immuntechnology, Lund University. The study included 315 blood samples and covered main autoimmune indications such as, Systemic Lupus Erythematosus Rheumatoid Arthritis (RA), Sjögren’s Syndrome, Systemic Vasculitis and healthy controls. For SLE, two sets of differential diagnosis data were previously reported March 7 2017.In this third data set,

Idogen participates in large Vinnova-initiative to make Sweden a leader in biological medicines

Idogen AB (”Idogen”) is a partner in a Vinnova project, awarded in total 48 million SEK in grants to run the cell and gene therapy project CAMP – Centre for Advanced Medical Products. Idogen will collaborate with, among others, AstraZeneca, GE Healthcare, Pfizer, all Swedish universities, several health care regions and research institutions to create an internationally recognized Centre for Advanced Medical Products. The project will have a duration of six years.Vinnova’s investment is part of an eight-year research program for biological drugs totaling 320 million SEK and is part of the

Insider transactions in Episurf Medical

Episurf Medical’s (NASDAQ: EPIS B) Chairman of the Board Dennis D. Stripe acquired shares in Episurf Medical on June 15 and he now owns 11,500 Class B-shares. Board member Laura Shunk has acquired shares in Episurf Medical on June 7 and she now owns 10,750 Class B-shares.  For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and

SL and Nobina develop transport services in Norrtälje and invest in electric buses

During Tuesday’s meeting of the Traffic Committee, the formal political decisions were made for an investment in electric buses in Norrtälje. This decision will enable a complete solution for the electrification of city transport in Norrtälje City. The aim is for the five electric buses to be rolled out in August 2018. The contract is part of the extension* that was approved in the autumn and extends until 2021.The electric buses are the result of a three-way collaboration between Nobina, SL and Norrtälje Municipality, with a focus on modern, sustainable and competitive public transport.

TetraGraph clinical use and comparison presented in ASA abstract

Uppsala, 21 June 2017. Senzime AB (publ) in partnership with Dr Réka Nemes at the University of Debrecen, Department of Anesthesiology and Intensive Care, Debrecen, Hungary, reports results from the Comparative Investigation of TOF-Watch SX and the TetraGraph.The results will be presented in October at the American Society of Anesthesiologists (ASA) Annual Meeting in Boston, USA. For more than 67 years, the ASA annual meeting has been the most comprehensive anesthesia-related educational event in the world, bringing together top influential and notable professionals in anesthesiology, pain

Isofol has initiated five additional study sites in the ISO-CC-005 study in which Modufolin® is evaluated in colorectal cancer

Isofol Medical AB (publ) announced today that the last one of five additional study sites was initiated in Greece and is now ready to start inclusion in the ISO-CC-005 study. The study sites were initiated in order to ensure the planned recruitment rate in the study and to offer additional investigators opportunity to familiarize themselves with the Modufolin® treatment prior the upcoming pivotal study, ISO-CC-007, scheduled to start late 2017.ISO-CC-005 is a Phase I/II open-label, multicenter clinical trial designed to identify the Modufolin® dose to be used in continued clinical

Bactiguard enters new partnership for South Africa

Bactiguard has entered partnership with Surgical Innovations Pty Ltd (“SI”), a company within the Medical arm of Ascendis Health, the JNB listed healthcare giant and leading supplier to the healthcare sector in South Africa.“Surgical Innovations is a leading provider of medical devices to both public and private hospitals, representing some of the most recognized international brands. As part of the Ascendis group they have an unsurpassed access to healthcare providers and in-depth understanding of how to address the South African market”, says Christian Kinch, CEO,Bactiguard. “We have

Castellum dives headfirst into digitalization – developing the office of the future in a new innovation lab

Castellum, large owner of commercial properties in growth cities from Copenhagen in the south to Sundsvall in the north, is now set to launch initiatives on several fronts to set the pace for digitalization of the industry. Development activities are being conducted in the Castellum Next20 innovation lab, a test arena for digital transformation and innovation. The first pilot project is due to be launched shortly.Castellum owns 700 buildings, where 250,000 people go to work every day. “New technology entails new possibilities and concrete changes for our daily working lives – the real

Vattenfall into UK energy retail with acquisition of iSupplyEnergy

iSupplyEnergy, a fast-growing UK supply company, has been acquired by Vattenfall, the Swedish energy group. After having recently entered the UK business customer market, Vattenfall will now start to sell electricity and natural gas for the first time also to private customers.Magnus Hall, President and CEO of Vattenfall, said: “Vattenfall is in Britain to grow and the acquisition of iSupplyEnergy is in line with Vattenfall’s strategy to grow our customer base in Northern Europe. Together with iSupplyEnergy, we will be able to supply a wide range of energy solutions and services to private

Aerogel launching Quartzene® in South Korea – dealer will initiate sales immediately

Svenska Aerogel – listed on Nasdaq First North – has signed an agreement with its first dealer in the South Korean market. JTC Jinwoo Trading Co. Ltd., which focuses its operations on specialty chemicals, will initiate sales in Q2. The company has an extensive network of customers within Aerogel’s Paint&Coatings business area.Svenska Aerogel is creating sales within its Paint&Coatings business area through a dealer network found in several geographic markets. “We are pleased with the growing interest in our solution. An increasing number of players are interested in marketing our

Digital disruption accelerating in the Nordics – most business models to become obsolete in 5 years

New study: Nordic executives expect more radical digital disruption in the very near future. More than seven out of ten believe their current business model will become obsolete in the next five years or earlier. Despite these challenges, digital disruptionalso presents numerous opportunities for developing new business and services – as well as the chance to lead future ecosystems. This is revealed in the newFuture Perspectives study conducted by Kairos Future on behalf of Tieto. In 2016 and 2017, Tieto conducted a study with 500 Nordic executives from a wide variety of industries

Catella: European office markets in an upswing

The new Catella Market Indicator, Office Europe 2017, offers an extensive view of the European office markets, looking at economic policy and performance. The future currently looks bright for real estate investors on the continent, primarily due exceptionally positive prospects for the coming years.Office prices continue to rise, resulting in yield compression in this segment. Our assessment of office investment prices includes classic core and core plus as well as, to a lesser extent, value-added properties. This conclusion describes the recent situation based on an analysis of 32

New date for publication of Vigmed Holding AB Interim Report for 1 January – 30 June 2017

The Board of Directors of Vigmed Holding AB have decided to postpone the publication of the Interim Report for 1 January – 30 June 2017, to 30 August 2017. The report was previously planned to be published on 24 August 2017. For more information contact:CEO Henrik Olsen, tel. +46 763-497 364Board member Georg Heftberger, tel. +43 664 884 106 83 In case of differences between the Swedish and English press releases, the Swedish press release shall prevail. Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk

The Board of Directors of Vigmed proposes a fully underwritten rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE, NEW ZEALAND OR JAPAN (OTHER THAN IN RELATION TO EXISTING SHAREHOLDERS AND TO SUCH EXTENT THAT IS GIVEN UNDER THE PROVISIONS REGARDING THE SO CALLED “SMALL NUMBER PRIVATE PLACEMENT” UNDER ARTICLE 2, PARAGRAPH 3, ITEM 2, SUB-ITEM (HA) OF THE FINANCIAL INSTRUMENTS AND EXCHANGE ACT OF JAPAN) OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.For more information regarding the rights issue, please refer to Vigmed

Change in Caverion’s Group Management Board: Head of Division Industrial Solutions will be replaced

Caverion Corporation Stock exchange release June 21, 2017 at 9.00 a.m. EESTChange in Caverion’s Group Management Board: Head of Division Industrial Solutions will be replaced  Sakari Toikkanen (born 1967, Lic (Tech.) has been appointed as Head of Division Industrial Solutions of Caverion Corporation as of June 21, 2017. He will assume the position until a new permanent head of division is hired. The recruitment process will be launched immediately. Sakari Toikkanen is currently Head of Strategy & IT & Communications of Caverion Corporation and a member of the Group Management Board.

There are no items matching the current filter
There are no more items matching the current filter
Back to top